One of the most important factors in healing is oxygen. Ozone helps improve oxygen delivery in your body by causing more oxygen to be released by hemoglobin and improving red blood cell flexibility, allowing the red blood cells to travel through small capillaries better.
Ozone also improves ATP production, increases key antioxidants and nitric oxide, which improves blood circulation, and modulates the immune system, increasing certain cytokines that reduce inflammation and decreasing certain cytokines that increase inflammation.
Read moreWhile COVID-19 meets the technical definition of a pandemic, the death toll is nowhere near that of earlier serious pandemics that would legitimately justify the extraordinary measures being deployed by the U.S. government.
An estimated 75 million to 200 million people in Eurasia and as much as 60% of the European population in rural areas were wiped out by the Black Death (bubonic plague) between 1347 and 1351.
The Spanish flu (swine flu), which hit during World War I in 1918, infected 500
Read moreBeing healthy and having a robust immune system is your primary defense against COVID-19. Aside from old age, people with underlying health conditions such as diabetes and heart disease are at increased risk of complications from the disease, and obesity has been found to be the biggest determinant for whether a patient will require hospitalization.
Read moreA diet of ultraprocessed food makes people more susceptible to COVID-19 by causing metabolic dysfunction and harm to the immune system.
Ultraprocessed food increases the risk of obesity, cancer, Type 2 diabetes, cardiovascular disease and gallstones and compromises the gut microbiome.
Read moreAs COVID-19 cases and deaths mount, hospital admissions for other acute ailments are markedly dropping. One possibility for this is that natural triggers of heart attack and stroke may have been removed by the imposed social distancing, eating at home and having more time for physical activity.
If patients are avoiding medical care for fear of contracting COVID-19, their condition may significantly worsen. If you suspect a heart attack, stroke or other serious acute condition, do not delay medical care.
Read moreNewsGuard recently announced that Mercola.com has been classified as fake news because we have reported the SARS-CoV-2 virus as potentially having been leaked from the biosafety level 4 laboratory in Wuhan City, China, the epicenter of the COVID-19 outbreak.
According to NewsGuard, “There is no evidence that the Wuhan Institute of Virology was the source of the outbreak, and genomic evidence has found that the virus is 96% identical at the whole-genome level to a bat coronavirus”.
NewsGuard’s position is in direct conflict with published scientific evidence suggesting this
Read moreAccording to the CDC, most COVID-19 cases are asymptomatic or mild, including in children, unless an individual has an underlying chronic health problem.
U.S. legislation did not include a cap placed on how much money drug companies can charge and profits they can make on the COVID-19 vaccines and drug therapies.
Dominated by the U.K.’s GlaxoSmithKline, France’s Sanofi and U.S. drug giants Merck and Pfizer, the vaccine market is projected to reach over $93 billion by 2026.
Read moreA hospital in New York City began universal screening for SARS-CoV-2, the virus that causes COVID-19, among pregnant women admitted for delivery. Overall, 87.9% of the women who tested positive for SARS-CoV-2 had no symptoms.
In a pilot study, 32% of 200 individuals tested positive for antibodies linked to COVID-19, but only about half said they’d experienced at least one COVID-19 symptom in the past four weeks.
Read moreThe authors of one study found evidence the risk of COVID-19 is higher in enclosed environments, such as at home or in transportation vehicles. German scientists cultured surfaces in one home where people were infected and did not find any live virus; a follow-up study is planned. Only one outbreak is known to have been passed outdoors.
Read moreA Chinese trial comparing clinical outcomes of COVID-19 patients treated with the antimalarial drug hydroxychloroquine and those receiving standard of care alone reports “disappointing” result.
The hydroxychloroquine group only had a 28-day negative conversion rate of 85.4% compared to the control group’s rate of 81.3%. No difference in the alleviation of symptoms was observed between the two groups.
The study did not, however, use supplemental zinc, which helps prevent viral replication. Evidence suggests hydroxychloroquine works for COVID-19 because it acts as a zinc
Read more
for Mercola on COVID-19